Published in Anticancer Res on January 11, 2007
Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol (2010) 2.71
Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors. Proc Natl Acad Sci U S A (2007) 1.41
High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma. Br J Cancer (2009) 1.24
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. Br J Cancer (2008) 1.21
Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation. Sci Rep (2013) 1.19
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125. Cancer Epidemiol Biomarkers Prev (2009) 1.16
Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway. J Exp Clin Cancer Res (2012) 1.08
Early detection biomarkers for ovarian cancer. J Oncol (2012) 0.95
Ascites analysis by a microfluidic chip allows tumor-cell profiling. Proc Natl Acad Sci U S A (2013) 0.89
Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy. Nanomedicine (2008) 0.87
An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findings. Curr Genomics (2009) 0.85
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors. J Ovarian Res (2011) 0.80
Expansion of anti-mesothelin specific CD4+ and CD8+ T cell responses in patients with pancreatic carcinoma. PLoS One (2014) 0.78
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator. Gene Ther (2015) 0.76
Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer. J Cancer (2017) 0.75
Prognostic biomarkers in ovarian cancer. Cancer Biomark (2011) 0.75
Ovarian cancer biomarkers: a focus on genomic and proteomic findings. Curr Genomics (2007) 0.75
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene (2003) 2.51
Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst (2011) 2.18
Prognostic factors affecting the outcome of brain metastases from breast cancer. Support Care Cancer (2006) 2.17
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell (2006) 2.13
A feasible strategy of preimplantation genetic diagnosis for carriers with chromosomal translocation: Using blastocyst biopsy and array comparative genomic hybridization. J Formos Med Assoc (2013) 2.08
Comparison of 3 Risk Estimation Methods for Predicting Cardiac Outcomes in Pregnant Women With Congenital Heart Disease. Circ J (2015) 2.00
First- and second-trimester Down syndrome screening: current strategies and clinical guidelines. Taiwan J Obstet Gynecol (2008) 1.65
Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results. Am J Obstet Gynecol (2010) 1.56
Post-coital vaginal douching is risky for non-regression of low-grade squamous intraepithelial lesion of the cervix. Gynecol Oncol (2010) 1.48
Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res (2004) 1.48
Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol (2003) 1.46
Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women. J Formos Med Assoc (2009) 1.44
LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population. J Formos Med Assoc (2007) 1.43
Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan. J Formos Med Assoc (2009) 1.40
The correlations of sexual activity, sleep problems, emotional distress, attachment styles with quality of life: comparison between gynaecological cancer survivors and noncancer women. J Clin Nurs (2013) 1.39
Submucous myoma induces uterine inversion. Taiwan J Obstet Gynecol (2006) 1.33
IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res (2010) 1.31
Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Crit Care Med (2007) 1.28
Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma. Cancer Res (2006) 1.25
Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol (2004) 1.23
The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett (2004) 1.23
Correlation of prenatal ultrasound and postnatal outcome in meconium peritonitis. Fetal Diagn Ther (2003) 1.19
Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol (2009) 1.17
Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema. Am J Respir Crit Care Med (2003) 1.16
Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol (2007) 1.16
Molecular genetic analysis of the TSC genes in two families with prenatally diagnosed rhabdomyomas. Prenat Diagn (2005) 1.15
c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair. J Biol Chem (2003) 1.14
Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin Chem (2007) 1.14
A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. Cancer Res (2005) 1.12
Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci (2005) 1.12
Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation. Int J Cancer (2003) 1.12
Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis. Mol Ther (2010) 1.11
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways. Biochem J (2012) 1.11
Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Cancer Res (2003) 1.10
Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases. Ann Saudi Med (2005) 1.10
In utero exposure to environmental lead and manganese and neurodevelopment at 2 years of age. Environ Res (2013) 1.10
Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up. Gynecol Oncol (2005) 1.09
Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol (2004) 1.09
Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One (2012) 1.06
Molecular and clinical analyses of 84 patients with tuberous sclerosis complex. BMC Med Genet (2006) 1.05
Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. Int J Cancer (2010) 1.03
Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography. J Pediatr (2008) 1.03
Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol (2014) 1.03
Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways. Toxicology (2008) 1.02
Postnatal outcome of fetal bradycardia without significant cardiac abnormalities. Am Heart J (2004) 1.02
Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol (2013) 1.01
Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1. Hum Mutat (2006) 1.01
Ruptured pseudoaneurysm of the external iliac artery in an advanced cervical cancer patient treated by endovascular covered stent placement. J Formos Med Assoc (2008) 1.01
Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test. Hum Mutat (2005) 1.01
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway. Biochem J (2009) 1.01
Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation. J Biol Chem (2004) 1.00
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response. Mol Oncol (2011) 1.00
Blastocyst biopsy and vitrification are effective for preimplantation genetic diagnosis of monogenic diseases. Hum Reprod (2013) 1.00
Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Carcinogenesis (2004) 1.00
IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan. Cancer Sci (2011) 1.00
Nationwide singleton birth weight percentiles by gestational age in Taiwan, 1998-2002. Acta Paediatr Taiwan (2006) 0.99
Pregnancy in patients on chronic dialysis: a single center experience and combined analysis of reported results. Eur J Obstet Gynecol Reprod Biol (2007) 0.97
Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms. J Hum Genet (2005) 0.97
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass. Gynecol Oncol (2012) 0.96
Newborn genetic screening for hearing impairment: a preliminary study at a tertiary center. PLoS One (2011) 0.96
Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J Biol Chem (2005) 0.95
PHOX2B mutation-confirmed congenital central hypoventilation syndrome in a Chinese family: presentation from newborn to adulthood. Chest (2009) 0.94
Intrauterine diagnosis of heterotaxy syndrome. Am Heart J (2002) 0.94
211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice. Pediatr Res (2011) 0.94
Fourteen non-CODIS autosomal short tandem repeat loci multiplex data from Taiwanese. Int J Legal Med (2010) 0.94
Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am J Gastroenterol (2009) 0.94
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer. Anticancer Res (2012) 0.93
The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions. J Psychosom Obstet Gynaecol (2010) 0.93